Showing results (151-160 of 195) with videos related to

Sort By:
Pageof 20
Cancer Medicine|December 15, 2017
SMG-1 inhibition by miR-192/-215 causes epithelial-mesenchymal transition in gastric carcinogenesis via activation of Wnt signalingXiaojing Zhang, Yin Peng, Yong Huang, et al.
The New England Journal of Medicine|April 28, 2025
Zongertinib in Previously Treated <i>HER2</i>-Mutant Non-Small-Cell Lung CancerJohn V Heymach, Gerrina Ruiter, Myung-Ju Ahn, et al.
Cancer Biology & Medicine|May 22, 2026
Efficacy and safety of first-line osimertinib in Chinese patients with EGFR-mutated advanced non-small cell lung cancer: a prospective, multicenter, non-interventional study (FLOURISH)Lisha Shen, Dongqing Lv, Ke-Jing Tang, et al.
JAMA Oncology|June 4, 2026
First-Line Serplulimab in Extensive-Stage Small Cell Lung Cancer: Secondary Analysis of the ASTRUM-005 Phase 3 Randomized Clinical TrialJingjing Liu, Liang Han, Lin Wu, et al.
Signal Transduction and Targeted Therapy|October 15, 2021
Toripalimab plus chemotherapy as second-line treatment in previously EGFR-TKI treated patients with EGFR-mutant-advanced NSCLC: a multicenter phase-II trialTao Jiang, Pingyang Wang, Jie Zhang, et al.
JAMA|September 27, 2022
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical TrialYing Cheng, Liang Han, Lin Wu, et al.
The Lancet. Respiratory Medicine|September 13, 2024
Savolitinib in patients in China with locally advanced or metastatic treatment-naive non-small-cell lung cancer harbouring MET exon 14 skipping mutations: results from a single-arm, multicohort, multicentre, open-label, phase 3b confirmatory studyYongfeng Yu, Qisen Guo, Yongchang Zhang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 22, 2023
D-1553 (Garsorasib), a Potent and Selective Inhibitor of KRAS<sup>G12C</sup> in Patients With NSCLC: Phase 1 Study ResultsZiming Li, Zhengbo Song, Yanqiu Zhao, et al.
The Lancet Regional Health. Western Pacific|April 6, 2026
Efficacy and safety of savolitinib in Chinese patients with locally advanced or metastatic <i>MET</i> exon 14-mutated non-small cell lung cancer: final results of a confirmatory Phase 3b studyYongfeng Yu, Qisen Guo, Yongchang Zhang, et al.
Eclinicalmedicine|October 28, 2025
Safety, pharmacokinetic, pharmacodynamic, and efficacy properties of orally administered APG-2449 in patients with advanced <i>ALK</i> <sup><i>+</i></sup> and <i>ROS1</i> <sup><i>+</i></sup> non-small-cell lung cancer: a multicentre, open-label, single-arm phase 1 trialYuxiang Ma, Zhengbo Song, Jianhua Chen, et al.
Pageof 20